Sanofi: Wayrilz Approved
Sanofi's Wayrilz is approved in Japan for immune thrombocytopenia based on the Luna 3 Phase 3 study
Sanofi’s Wayrilz Approved In Japan For Immune Thrombocytopenia: Approval Based On Luna 3 Phase 3 Study
Sanofi's Wayrilz is approved in Japan for immune thrombocytopenia based on the Luna 3 Phase 3 study
Sanofi’s Wayrilz Approved In Japan For Immune Thrombocytopenia: Approval Based On Luna 3 Phase 3 Study